<- Go Home
NIOX Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Market Cap
GBP 287.5M
Volume
1.0M
Cash and Equivalents
GBP 11.8M
EBITDA
GBP 12.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 32.7M
Profit Margin
71.09%
52 Week High
GBP 0.78
52 Week Low
GBP 0.53
Dividend
1.82%
Price / Book Value
4.39
Price / Earnings
60.69
Price / Tangible Book Value
7.84
Enterprise Value
GBP 276.9M
Enterprise Value / EBITDA
21.14
Operating Income
GBP 9.3M
Return on Equity
6.70%
Return on Assets
7.33
Cash and Short Term Investments
GBP 11.8M
Debt
GBP 1.2M
Equity
GBP 64.4M
Revenue
GBP 46.0M
Unlevered FCF
GBP 13.6M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium